PLAT and stroke disorder: Currently, thrombolytic therapy with tissue plasminogen activator (tPA) still remains the first option for the treatment of ischemic stroke, although only a small population of patients have seen any clinical benefits due to its narrow therapeutic window after stroke onset [1].